Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus


  1. 2016
  2. Published

    Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO

    Sørensen, Per Soelberg, 2016, In: Multiple Sclerosis. 22, 10, p. 1260-1263 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Inverse comorbidity in multiple sclerosis: Findings in a complete nationwide cohort

    Thormann, A., Koch-Henriksen, N., Laursen, B., Sørensen, Per Soelberg & Magyari, M., 2016, In: Multiple Sclerosis and Related Disorders. 10, p. 181-186 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis

    Ratzer, R., Iversen, P., Börnsen, L., Dyrby, T. B., Christensen, J. R., Ammitzbøll, C., Madsen, C. G., Garde, Ellen, Lyksborg, M., Andersen, B., Hyldstrup, L., Sørensen, Per Soelberg, Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2016, In: Multiple Sclerosis Journal. 22, 7, p. 926–934 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Multiple sclerosis: Generic glatiramer acetate-a step toward cheaper MS drugs?

    Sørensen, Per Soelberg, 2016, In: Nature Reviews. Neurology. 12, 1, p. 5-6 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  6. Published

    Neurofilament in CSF—A biomarker of disease activity and long-term prognosis in multiple sclerosis

    Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, 2016, In: Multiple Sclerosis. 22, 9, p. 1112-1113 2 p.

    Research output: Contribution to journalEditorialResearchpeer-review

  7. Published

    Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis

    Bachelet, D., Hässler, S., Mbogning, C., Link, J., Ryner, M., Ramanujam, R., Auer, M., Jensen, P. E. H., Koch-Henriksen, N., Warnke, C., Ingenhoven, K., Buck, D., Grummel, V., Lawton, A., Donnellan, N., Hincelin-Mery, A., Sikkema, D., Pallardy, M., Kieseier, B., Hemmer, B. & 8 others, Hartung, H. P., Sørensen, Per Soelberg, Deisenhammer, F., Dönnes, P., Davidson, J., Fogdell-Hahn, A., Broët, P. & ABIRISK Consortium, A. C., 2016, In: P L o S One. 11, 11, p. 1-19 19 p., e0162752.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    The potential role for ocrelizumab in the treatment of multiple sclerosis: Current evidence and future prospects

    Sørensen, Per Soelberg & Blinkenberg, M., 2016, In: Therapeutic Advances in Neurological Disorders. 9, 1, p. 44-52 9 p.

    Research output: Contribution to journalReviewResearchpeer-review

  9. 2015
  10. Published

    Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis

    Olsson, A., Oturai, D. B., Sørensen, Per Soelberg, Oturai, P. S. & Oturai, A. B., Oct 2015, In: Multiple Sclerosis Journal. 21, 12, p. 1557-65 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

    Taylor, J. C., Martin, H. C., Lise, S., Broxholme, J., Cazier, J-B., Rimmer, A., Kanapin, A., Lunter, G., Fiddy, S., Allan, C., Aricescu, A. R., Attar, M., Babbs, C., Becq, J., Beeson, D., Bento, C., Bignell, P., Blair, E., Buckle, V. J., Bull, K. & 90 others, Cais, O., Cario, H., Chapel, H., Copley, R. R., Cornall, R., Craft, J., Dahan, K., Davenport, E. E., Dendrou, C., Devuyst, O., Fenwick, A. L., Flint, J., Fugger, Lars, Gilbert, R. D., Goriely, A., Green, A., Greger, I. H., Grocock, R., Gruszczyk, A. V., Hastings, R., Hatton, E., Higgs, D., Hill, A., Holmes, C., Howard, M., Hughes, L., Humburg, P., Johnson, D., Karpe, F., Kingsbury, Z., Kini, U., Knight, J. C., Krohn, J., Lamble, S., Langman, C., Lonie, L., Luck, J., McCarthy, D., McGowan, S. J., McMullin, M. F., Miller, K. A., Murray, L., Németh, A. H., Nesbit, M. A., Nutt, D., Ormondroyd, E., Oturai, A. B., Pagnamenta, A., Patel, S. Y., Percy, M., Petousi, N., Piazza, P., Piret, S. E., Polanco-Echeverry, G., Popitsch, N., Powrie, F., Pugh, C., Quek, L., Robbins, P. A., Robson, K., Russo, A., Sahgal, N., van Schouwenburg, P. A., Schuh, A., Silverman, E., Simmons, A., Sørensen, Per Soelberg, Sweeney, E., Taylor, J., Thakker, R. V., Tomlinson, I., Trebes, A., Twigg, S. R. F., Uhlig, H. H., Vyas, P., Vyse, T., Wall, S. A., Watkins, H., Whyte, M. P., Witty, L., Wright, B., Yau, C., Buck, D., Humphray, S., Ratcliffe, P. J., Bell, J. I., Wilkie, A. O. M., Bentley, D., Donnelly, P. & McVean, G., Jul 2015, In: Nature Genetics. 47, 7, p. 717-26 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis

    Marrie, R. A., Reider, N., Cohen, J., Stuve, O., Sørensen, Per Soelberg, Cutter, G., Reingold, S. C. & Trojano, M., Mar 2015, In: Multiple Sclerosis. 21, 3, p. 282-293 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

Previous 1...7 8 9 10 11 12 13 14 ...26 Next

ID: 11025